Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-01-2017 | Research

Trends of medical expenditures and quality of life in US adults with diabetes: the medical expenditure panel survey, 2002–2011

Authors: Jennifer A. Campbell, Kinfe G. Bishu, Rebekah J. Walker, Leonard E. Egede

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Studies indicate a relationship between cost and quality of life (QOL) in diabetes care, however, the interaction is complex and the relationship is not well understood. The aim of this study was to 1) examine the relationship of quartiles of QOL on cost amongst U.S. adults with diabetes, 2) investigate how the relationship may change over time, and 3) examine the incremental effect of QOL on cost while controlling for other relevant covariates.

Methods

Data from 2002–2011 Medical Expenditure Panel Survey (MEPS) was used to examine the association between QOL and medical expenditures among adults with diabetes (aged ≥18 years) N = 20,442. Unadjusted means were computed to compare total healthcare expenditure and the out-of-pocket expenses by QOL quartile categories. QOL measures were Physical Component Summary (PCS) and Mental Component Summary (MCS) derived from the Short-Form 12. A two-part model was then used to estimate adjusted incremental total healthcare expenditure and out-of-pocket expenses adjusting for relevant covariates.

Results

Differences between the highest and lowest quartiles totaled $11,801 for total expenditures and $989 for out-of-pocket expenses. Over time, total expenditures remained stable, while out-of-pocket expenses decreased, particularly for the lowest quartile of physical component of QOL. Similar trends were seen in the mental component, however, differences between quartiles were smaller (average $5,727 in total expenses; $287 in out-of-pocket). After adjusting for covariates, those in the highest quartile of physical component of QOL spent $7,500 less, and those in the highest quartile of mental component spent $3,000 less than those in the lowest quartiles.

Conclusions

A clear gradient between QOL and cost with increasing physical and mental QOL associated with lower expenditures and out-of-pocket expenses was found. Over a 10-year time period those with the highest physical QOL had significantly less medical expenditures compared to those with the lowest physical QOL. This study demonstrates the significant individual and societal impact poor QOL has on patients with diabetes. Understanding how differences in a subjective measure of health, such as QOL, has on healthcare expenditures helps reveal the burden of disease not reflected by using only behavioral and physiological measures.
Literature
4.
go back to reference Boyle J, Thompson T, Gregg E, Barker L, Williamson D. Projections of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:1–12.CrossRef Boyle J, Thompson T, Gregg E, Barker L, Williamson D. Projections of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:1–12.CrossRef
6.
go back to reference Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care. 2000;23:1654–9.CrossRefPubMed Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care. 2000;23:1654–9.CrossRefPubMed
8.
go back to reference Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med. 1999;159:1873–80.CrossRefPubMed Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med. 1999;159:1873–80.CrossRefPubMed
9.
go back to reference Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–81.CrossRefPubMed Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–81.CrossRefPubMed
10.
go back to reference Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008;46:287–92.CrossRefPubMed Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008;46:287–92.CrossRefPubMed
11.
go back to reference Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care. 2008;14:791–8.PubMed Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care. 2008;14:791–8.PubMed
12.
go back to reference U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125–36.CrossRef U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125–36.CrossRef
13.
go back to reference Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235–41.CrossRefPubMed Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235–41.CrossRefPubMed
14.
go back to reference Glasziou P, Alexander J, Beller E, Clarke P, the ADVANCE Collaborative Group. Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Heath Qual Life Outcomes. 2007;5:21–31.CrossRef Glasziou P, Alexander J, Beller E, Clarke P, the ADVANCE Collaborative Group. Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Heath Qual Life Outcomes. 2007;5:21–31.CrossRef
15.
go back to reference Anandacoomarasamy A, Caterson ID, Leibman S, Smith GS, Sambrook PN, Fransen M, March LM. Influence of BMI on health-related quality of life: comparison between an obese adult cohort and age-matched population norms. Obesity. 2009;17:2114–8.CrossRefPubMed Anandacoomarasamy A, Caterson ID, Leibman S, Smith GS, Sambrook PN, Fransen M, March LM. Influence of BMI on health-related quality of life: comparison between an obese adult cohort and age-matched population norms. Obesity. 2009;17:2114–8.CrossRefPubMed
16.
go back to reference Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005;22:1482–6.CrossRefPubMed Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005;22:1482–6.CrossRefPubMed
17.
go back to reference Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQOL VAS and SF-6D. Int J Obes. 2007;31:189–96.CrossRef Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQOL VAS and SF-6D. Int J Obes. 2007;31:189–96.CrossRef
18.
go back to reference Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458–63.CrossRefPubMed Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458–63.CrossRefPubMed
19.
go back to reference Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan R, Herman WH. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238–43.CrossRefPubMed Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan R, Herman WH. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238–43.CrossRefPubMed
20.
go back to reference Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102–9.CrossRefPubMed Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102–9.CrossRefPubMed
21.
go back to reference Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384–91.CrossRefPubMed Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384–91.CrossRefPubMed
22.
go back to reference Economic costs of diabetes in the U.S. In 2007. American Diabetes Association Diabetes Care. 2008; 31(3):596-615. Economic costs of diabetes in the U.S. In 2007. American Diabetes Association Diabetes Care. 2008; 31(3):596-615.
23.
go back to reference Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30:2478–83.CrossRefPubMedPubMedCentral Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30:2478–83.CrossRefPubMedPubMedCentral
28.
go back to reference Galbraith AA, Wong ST, Kim SE, Newacheck PW. Out-of-pocket financial burden for low-income families with children: socioeconomic disparities and effects of insurance. Health Serv Res. 2005;40:1722–36.CrossRefPubMedPubMedCentral Galbraith AA, Wong ST, Kim SE, Newacheck PW. Out-of-pocket financial burden for low-income families with children: socioeconomic disparities and effects of insurance. Health Serv Res. 2005;40:1722–36.CrossRefPubMedPubMedCentral
29.
go back to reference Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, Silbergeld EK. Blood lead, blood pressure, and hypertension in Perimenopausal and postmenopausal women. JAMMA. 2003;289:1523–32.CrossRef Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, Silbergeld EK. Blood lead, blood pressure, and hypertension in Perimenopausal and postmenopausal women. JAMMA. 2003;289:1523–32.CrossRef
30.
go back to reference Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analysis in clinical trials. N Engl J Med. 2007;357(21):2189–94.CrossRefPubMed Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analysis in clinical trials. N Engl J Med. 2007;357(21):2189–94.CrossRefPubMed
31.
go back to reference Cameroon AC, Trivedi PK. Microeconometrics using stata. revisedth ed. College Station: StataCorp LP; 2010. Cameroon AC, Trivedi PK. Microeconometrics using stata. revisedth ed. College Station: StataCorp LP; 2010.
32.
go back to reference Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–94.CrossRefPubMed Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–94.CrossRefPubMed
33.
go back to reference Belotti F, Deb P, Manning WG, Norton EC. Tpm: estimating two-part models. Stata J. 2012;5:1–13. Belotti F, Deb P, Manning WG, Norton EC. Tpm: estimating two-part models. Stata J. 2012;5:1–13.
34.
go back to reference Mihaylova B, Briggs A, O’Hhagan, Thompson SG. Review of statistical methods for analyzing healthcare resources and costs. Health Econ. 2011;20:897–916.CrossRefPubMed Mihaylova B, Briggs A, O’Hhagan, Thompson SG. Review of statistical methods for analyzing healthcare resources and costs. Health Econ. 2011;20:897–916.CrossRefPubMed
35.
go back to reference Egede LE, Walker RJ, Bishu K, Dismuke CE. Trends in costs of depression in adults with diabetes in the United States: medical expenditure panel survey, 2004-2011. J Gen Intern Med. 2016;31(6):615–22.CrossRefPubMed Egede LE, Walker RJ, Bishu K, Dismuke CE. Trends in costs of depression in adults with diabetes in the United States: medical expenditure panel survey, 2004-2011. J Gen Intern Med. 2016;31(6):615–22.CrossRefPubMed
36.
go back to reference Blakesley RE, Mazumdar S, Dew MA, Houck PR, Reynolds 3rd CF, Butters MA. Comparisons of methods for multiple hypothesis testing in neuropsychological research. Neuropsychology. 2009;23:255–64.CrossRefPubMedPubMedCentral Blakesley RE, Mazumdar S, Dew MA, Houck PR, Reynolds 3rd CF, Butters MA. Comparisons of methods for multiple hypothesis testing in neuropsychological research. Neuropsychology. 2009;23:255–64.CrossRefPubMedPubMedCentral
37.
go back to reference Ozkaya G, Ercan I. Examining multiple comparison procedures according to error rate, power type and false discovery rate. J Mod App Stat Methods. 2012;11:348–60. Ozkaya G, Ercan I. Examining multiple comparison procedures according to error rate, power type and false discovery rate. J Mod App Stat Methods. 2012;11:348–60.
38.
go back to reference Kivits J, Erpelding ML, Guillemin F. Social determinants of health-related quality of life. Rev Epidemiol Sante Publique. 2013;61 Suppl 3:S189–94.CrossRefPubMed Kivits J, Erpelding ML, Guillemin F. Social determinants of health-related quality of life. Rev Epidemiol Sante Publique. 2013;61 Suppl 3:S189–94.CrossRefPubMed
39.
go back to reference Walker RJ, Williams JS, Egede LE. Influence of race, ethnicity, and social determinants of health on diabetes outcomes. Am J Med Sciences. 2016;351(4):366–73.CrossRef Walker RJ, Williams JS, Egede LE. Influence of race, ethnicity, and social determinants of health on diabetes outcomes. Am J Med Sciences. 2016;351(4):366–73.CrossRef
Metadata
Title
Trends of medical expenditures and quality of life in US adults with diabetes: the medical expenditure panel survey, 2002–2011
Authors
Jennifer A. Campbell
Kinfe G. Bishu
Rebekah J. Walker
Leonard E. Egede
Publication date
01-01-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0651-7

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue